FealtySign in

CONAGRA BRANDS INC.

(CAG)

CIK 23217 · SEC filings only

Not gradedDividend record
shown as history
company entity
63 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

63 declarations · 9 raised · 51 held · 1 cut · held 31 quarters

  1. NOTED$0.1750/shperiod ended 2026-08-30Filing ↗
  2. HELD$0.3500/shperiod ended 2026-02-22Filing ↗
  3. HELD$0.3500/shperiod ended 2025-11-23Filing ↗
  4. HELD$0.3500/shperiod ended 2025-08-24Filing ↗
  5. HELD$0.3500/shperiod ended 2025-02-23Filing ↗
  6. HELD$0.3500/shperiod ended 2024-11-24Filing ↗
  7. HELD$0.3500/shperiod ended 2024-08-25Filing ↗
  8. HELD$0.3500/shperiod ended 2024-02-25Filing ↗
  9. HELD$0.3500/shperiod ended 2023-11-26Filing ↗
  10. RAISED$0.3500/shperiod ended 2023-08-27Filing ↗
  11. HELD$0.3300/shperiod ended 2023-02-26Filing ↗
  12. HELD$0.3300/shperiod ended 2022-11-27Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
1 resolved promise

Sector median (Manufacturing): B across 8 graded companies

Not enough resolved promises to grade

1 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

The Company expects to repurchase approximately $1.1 billion of shares of its common stock in the fiscal year

unresolved — no outcome on file$1.10Breceipt (opens in a new tab)

Credibility timeline

MISSED · Oct 7, 2021
20212021
Timeline as a list
  • Oct 7, 2021MISSEDThe Company’s total current authorization is approximately $1.4 billion
1 resolved buyback promise · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
Not yet gradedGuidance record
harness minimum not met
company entity
1 resolved promise

Sector median (Manufacturing): A across 27 graded companies

Not enough comparable guidance to grade

1 of the 4 resolved guidance promises needed to publish a reliability grade. Some of this company’s guidance has no reported figure we can compare it with. It is shown below, never scored; the line under each statement says why. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

24 of 25 guidance figures that were graded or dropped for basis could not be graded on the same basis (96%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · non-GAAPcannot be graded190613
Revenue · basis not stated141013
EPS · non-GAAPcannot be graded3401420
EPS · basis not statedcannot be graded9045

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (70)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Sep 30, 2026
    Adjusted EPS between $1.40 and $1.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. revenue guidance fy · Sep 30, 2026
    Organic net sales change of (3)% to (1)% compared to fiscal 2026
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Jul 15, 2026
    Adjusted EPS between $1.40 and $1.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. revenue guidance fy · Jul 15, 2026
    Organic net sales change of (3)% to (1)% compared to fiscal 2026
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. revenue guidance fy · Apr 1, 2026
    Organic net sales change near the midpoint of its (1)% to 1% range
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Apr 1, 2026
    Adjusted EPS of approximately $1.70, at the low end of its $1.70 to $1.85 range
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. revenue guidance fy · Dec 19, 2025
    Organic net sales change of (1)% to 1% compared to fiscal 2025
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Dec 19, 2025
    Adjusted EPS between $1.70 and $1.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. revenue guidance fy · Oct 1, 2025
    Organic net sales growth of (1)% to 1% compared to fiscal 2025
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Oct 1, 2025
    Adjusted EPS between $1.70 and $1.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. revenue guidance fy · Jul 10, 2025
    Organic net sales growth of (1)% to 1% compared to fiscal 2025
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Jul 10, 2025
    Adjusted EPS between $1.70 and $1.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. revenue guidance fy · Apr 3, 2025
    Organic net sales of approximately (2)% compared to fiscal 2024
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Apr 3, 2025
    Adjusted EPS of approximately $2.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Dec 19, 2024
    Adjusted EPS between $2.45 and $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. revenue guidance fy · Dec 19, 2024
    Organic net sales near the midpoint of (1.5)% to flat compared to fiscal 2024
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. revenue guidance fy · Oct 2, 2024
    Organic net sales of (1.5)% to flat compared to fiscal 2024
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Oct 2, 2024
    Adjusted EPS between $2.60 and $2.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Jul 11, 2024
    Adjusted EPS between $2.60 and $2.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. revenue guidance fy · Jul 11, 2024
    Organic net sales of (1.5)% to flat compared to fiscal 2024
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance q · Apr 7, 2022
    Adjusted EPS is expected to be approximately $0.64
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. revenue guidance q · Apr 7, 2022
    Organic net sales growth is expected to be approximately +7%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  23. revenue guidance fy · Apr 7, 2022
    Organic net sales growth is expected to be approximately +4%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  24. eps guidance fy · Apr 7, 2022
    Adjusted EPS is expected to be approximately $2.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. revenue guidance fy · Jan 6, 2022
    Organic net sales growth is expected to be approximately +3%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  26. eps guidance fy · Jan 6, 2022
    Adjusted EPS is expected to be approximately $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Oct 7, 2021
    Adjusted EPS is expected to be approximately $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. revenue guidance fy · Oct 7, 2021
    Organic net sales growth is expected to be approximately +1%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  29. eps guidance fy · Jul 13, 2021
    Adjusted EPS is expected to be approximately $2.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. revenue guidance fy · Jul 13, 2021
    Organic net sales growth is expected to be approximately flat compared to fiscal 2021
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. revenue guidance q · Apr 8, 2021
    Organic net sales growth is expected in the range of (10)% to (12)%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance q · Apr 8, 2021
    Adjusted EPS is expected in the range of $0.49 to $0.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Apr 8, 2021
    Adjusted EPS of $2.63 to $2.73
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. revenue guidance fy · Apr 8, 2021
    Organic net sales growth (3-year CAGR ending fiscal 2022) of +1% to +2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. revenue guidance fy · Jan 7, 2021
    Organic net sales growth (3-year CAGR ending fiscal 2022) of +1% to +2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. revenue guidance q · Jan 7, 2021
    Organic net sales growth of +6% to +8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance fy · Jan 7, 2021
    Adjusted EPS of $2.66 to $2.76
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance q · Jan 7, 2021
    Adjusted EPS of $0.56 to $0.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance q · Jun 30, 2020
    Adjusted EPS of $0.54 to $0.59
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Jun 30, 2020
    Adjusted EPS of $2.66 to $2.76
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. revenue guidance fy · Jun 30, 2020
    Organic net sales growth (3-year CAGR ending fiscal 2022) of 1% to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. revenue guidance q · Jun 30, 2020
    Organic net sales growth of 10% to 13%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance fy · Mar 31, 2020
    $2.00 to $2.07
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. revenue guidance fy · Sep 26, 2019
    Organic net sales growth of 1.0% to 1.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · Sep 26, 2019
    Adjusted EPS in the range of $2.08 to $2.18
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance fy · Jun 27, 2019
    The Company now expects adjusted fiscal 2020 adjusted EPS in the range of $2.08 to $2.18
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. revenue guidance fy · Jun 27, 2019
    Organic net sales growth of 1.0% to 1.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  48. eps guidance fy · Jun 27, 2019
    Adjusted EPS in fiscal 2022 of $2.68 to $2.78
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. revenue guidance fy · Dec 20, 2018
    $1.70 to $1.75 billion
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  50. revenue guidance fy · Dec 20, 2018
    +1.0% to +2.0%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  51. eps guidance fy · Dec 20, 2018
    $2.03 to $2.08
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance q · Jun 27, 2018
    Adjusted diluted EPS in the range of $0.46 to $0.49
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. revenue guidance fy · Jun 27, 2018
    Reported net sales growth in the range of 0.5% to 1.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  54. eps guidance fy · Sep 28, 2017
    Adjusted diluted EPS from continuing operations in the range of $1.84 to $1.89
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  55. eps guidance fy · Mar 23, 2017
    Adjusted diluted EPS is expected to be at or slightly above the high-end of the $1.65 to $1.70 range.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. revenue guidance fy · Mar 23, 2017
    Net sales (excluding the impacts of divestitures and foreign exchange) are expected to be at or slightly below the low-end of the range of down 4% to 5%.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · Apr 7, 2016
    The company expects full year fiscal 2016 diluted EPS from continuing operations, adjusted for items impacting comparability, to be in the range of $2.05 - $2.07.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. eps guidance q · Sep 22, 2015
    the company expects diluted EPS, adjusted for items impacting comparability, to be approximately in line with year-ago comparable amounts
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance fy · Mar 26, 2015
    The company now expects fiscal 2015 diluted EPS, adjusted for items impacting comparability, to be in the range of $2.15-$2.19.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. eps guidance fy · Dec 18, 2014
    The company continues to expect fiscal 2015 diluted EPS, adjusted for items impacting comparability, to show a mid-single digit rate of growth over the comparable diluted EPS of $2.17 earned in fiscal 2014.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance fy · Jun 26, 2014
    The company expects fiscal 2015 EPS to reflect a mid-single digit rate of growth over the comparable fiscal 2014 EPS of $2.17.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance fy · Mar 20, 2014
    the company expects comparable EPS growth in fiscal 2015 at a rate lower than the original double-digit target
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. eps guidance fy · Mar 20, 2014
    The company continues to expect fiscal 2014 diluted EPS, adjusted for items impacting comparability, to be in the range of $2.22-$2.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  64. eps guidance fy · Sep 19, 2013
    The company currently expects fiscal 2014 diluted EPS, adjusted for items impacting comparability, to be approximately $2.34-$2.38.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance q · Sep 19, 2013
    the company expects its fiscal 2014 second-quarter diluted EPS to be in the range of $0.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · Jun 27, 2013
    EPS in excess of $3.00 per share in fiscal 2017
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  67. eps guidance fy · Jun 27, 2013
    long-term annual diluted EPS growth of 7-9%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  68. eps guidance fy · Jun 27, 2013
    Annual diluted EPS growth of at least 10%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  69. eps guidance fy · Jun 27, 2013
    Fiscal 2014 diluted EPS, adjusted for items impacting comparability, to be approximately $2.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  70. eps guidance fy · Dec 20, 2012
    The company now expects EPS expectations for the full fiscal year, adjusted for items impacting comparability, to be at least $2.06
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (2) · 3 superseded

Open · revenue guidance fy

Reported net sales growth in the range of (2)% to flat

unresolved — no outcome on filereceipt (opens in a new tab)
Open · revenue guidance fy

Above high end of range

unresolved — no outcome on filereceipt (opens in a new tab)
Superseded · revenue guidance fy

long-term annual sales growth in the range of 3-4%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Reported net sales growth of 13.5% to 14.0%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Reported net sales growth of 13.5% to 14.0%

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

BELOW · Oct 2, 2018
20182018
Timeline as a list
  • Oct 2, 2018BELOWReported net sales growth in the range of 2.0% to 2.5%
1 resolved guidance promise · 70 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →